Literature DB >> 11216484

Metabolic fate of luteolin and its functional activity at focal site.

K Shimoi1, N Saka, K Kaji, R Nozawa, N Kinae.   

Abstract

Luteolin has been shown to possess potent antioxidant and anti-inflammatory/anti-allergic activities. In order to evaluate a chemopreventive role of luteolin in inflammatory responses involved in the pathogenesis of atherosclerosis and cancer etc., the metabolic fate of luteolin in rats and humans was investigated by HPLC analysis, and its effect on cell surface expression of adhesion molecules in human umbilical vein endothelial cells(HUVECs) was examined by ELISA. Luteolin monoglucuronide, which was a main metabolite, and free luteolin were detected in rat plasma and human serum. Luteolin monoglucuronide was hydrolyzed to free luteolin by beta-glucuronidase released from neutrophils stimulated with lonomycin and Cytocharasine B. Luteolin suppressed the TNF-alpha induced ICAM-1 expression significantly. Among nine flavonoids (40 microM) examined, chrysin, apigenine, quercetin and galangin also demonstrated suppressive effct on it. These results suggest the posssibility that deconjugation of luteolin monoglucuronide occurs and that free luteolin showed functional acyivities such as suppression of TNF-alpha induced ICAM- 1 expression at inflammation site.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11216484     DOI: 10.1002/biof.5520120129

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  14 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 2.  Perspectives for cancer prevention with natural compounds.

Authors:  A R M Ruhul Amin; Omer Kucuk; Fadlo R Khuri; Dong M Shin
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

Review 3.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

4.  Anti-inflammatory and antioxidant activities of ethanolic extract of aerial parts of Vernonia patula (Dryand.) Merr.

Authors:  Arpona Hira; Shubhra Kanti Dey; Md Sariful Islam Howlader; Arif Ahmed; Hemayet Hossain; Ismet Ara Jahan
Journal:  Asian Pac J Trop Biomed       Date:  2013-09-04

5.  Metabolic Disposition of Luteolin Is Mediated by the Interplay of UDP-Glucuronosyltransferases and Catechol-O-Methyltransferases in Rats.

Authors:  Liping Wang; Qingwei Chen; Lijun Zhu; Qiang Li; Xuejun Zeng; Linlin Lu; Ming Hu; Xinchun Wang; Zhongqiu Liu
Journal:  Drug Metab Dispos       Date:  2016-12-28       Impact factor: 3.922

6.  Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.

Authors:  A R M Ruhul Amin; Dongsheng Wang; Hongzheng Zhang; Shifang Peng; Hyung Ju C Shin; Johann C Brandes; Mourad Tighiouart; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

7.  Breast cancer resistance protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing UDP-glucuronosyltransferase 1A9.

Authors:  Lan Tang; Ye Li; Wei-Ying Chen; Shan Zeng; Ling-Na Dong; Xiao-Juan Peng; Wen Jiang; Ming Hu; Zhong-Qiu Liu
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

8.  Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites.

Authors:  Jeremy P E Spencer; Gunter G C Kuhnle; Robert J Williams; Catherine Rice-Evans
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

9.  The flavonoid luteolin induces nitric oxide production and arterial relaxation.

Authors:  Hongwei Si; Richard P Wyeth; Dongmin Liu
Journal:  Eur J Nutr       Date:  2013-04-21       Impact factor: 5.614

10.  Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.

Authors:  Zohara Sternberg; Kailash Chadha; Alicia Lieberman; Allison Drake; David Hojnacki; Bianca Weinstock-Guttman; Frederick Munschauer
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.